Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)

NCT02182986 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT02182986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02182986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children (CTOTC-06)
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
August 14, 2014
Completion date
May 15, 2019
Enrollment
944 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

ebv-related ptld, heart transplant, kidney transplant, liver transplant, ptlds, small intestine transplant